The urinary excretion of metabolites of 2,3-benzofuran was studied in Sprague-Dawley rats (n ‫؍‬ 5) given a single dose of 150 mg/kg i.p. Urine samples were collected at defined intervals up to 7 days postdose and analyzed using 1 H NMR and directly coupled high
The general population is potentially exposed to 2,3-benzofuran (BF 4 ) through its release into the environment as a result of waste incineration (Junk and Ford, 1980) and from exhaust gases from gasoline and diesel engines (Seizinger and Dimitriades, 1972; Hampton et al., 1982) . The use of BF in the manufacture of coumaroneindene resins is an industrial hazard and may result in environmental contamination with BF via various waste streams (Budavari, 1989) . Additionally, BF has been detected in drinking (Svec et al., 1974) and ground water (Rostad et al., 1985) , coffee aroma (Silwar and Tressl, 1989) , and human milk (Pellizzari et al., 1982) , and it is a component of coal tar (McNeil, 1983) . The probability of human exposure to BF has led to limited work on hazard identification being carried out. BF induces lesions in the liver and kidney in both mouse and rat (Connelly, 1983; National Toxicology Program, 1989) and is associated with intrahepatic cholestasis in the rat after short periods of daily i.p. administration (Connelly, 1983) .
It was concluded by IARC (1995) that BF presents a risk of carcinogenicity in humans as studies have shown BF to be genotoxic in the mouse and carcinogenic in both the mouse and female rat. However, the role of metabolism in the clearance of toxicity of BF has not been fully characterized. The current work was initiated to identify the urinary metabolites of BF, as part of a wider study to determine the significance of metabolism of BF and the validity of the rat as a model for human risk assessment.
Directly coupled HPLC-NMR has proved useful for the metabolic profiling of xenobiotics via structural characterization of their metabolites (Albert, 1995; Lindon et al., 1996) . However, NMR spectroscopic methods are not always sufficient for metabolite structure elucidation, for example in the determination of sulfate conjugates, because the introduced moiety does not contain NMR-detectable nuclei. In such cases, directly coupled HPLC-NMR with parallel MS has the potential to allow full structural characterization of xenobiotic metabolites in a complex biological matrix in a single chromatographic run (Shockcor et al., 1996; Abel et al., 1999; Bailey et al., 2000) . By combining the NMR and MS data acquisition in a directly coupled system, the problems of synchronizing LC-MS and HPLC-NMR data are overcome. Here, we apply this approach to identify the metabolites of BF in the urine of rats given BF intraperitoneally. (Connelly, 1983) . The lowest dose of BF producing detectable histopathological changes in the liver (increased incidence and degree of focal inflammatory cell infiltration with associated single cell necrosis) was determined as 150 mg/kg and hence was selected as the dose level for the current study.
Fifteen male Sprague-Dawley (SD), aged 9 to 10 weeks, were placed in grid-based plastic cages (North Kent Plastics, Rochester, Kent, UK). Animals Animals were given access to water and food (pelleted irradiated Rat and Mouse Diet 1; Special Diet Services, Witham, Essex) ad libitum and kept at a temperature of 21 Ϯ 2°C. Groups of five rats were given either a single i.p. dose of BF (150 mg/kg) or saline (controls). Urine was collected over the following time periods: predose (Ϫ24 -0 h), and at 0 to 8 h, 8 to 24 h, 24 to 32 h, 32 to 48 h, 48 to 72 h, 72 to 96 h, 96 to 120 h, 120 to 144 h and 144 to 168 h postdose. All urine samples were collected into labeled tubes over solid CO 2 and stored at Ϫ20°C until analysis. All animals were killed by cervical dislocation after collection of the final urine sample. A separate group of rats (n ϭ 5) was dosed with BF and killed after 48 h to assess tissue pathology. Major organs, including the liver and kidney, were fixed in 10% buffered formol saline, processed through paraffin wax, sectioned, and stained with hematoxylin and eosin for examination by light microscopy.
Offline Metabolites A and B were separated by SPEC of SD urine, using a C 18 column and step-wise methanol gradient. These metabolites were present predominantly in (a) the 80% and (b) the 40% methanol washes, respectively, although metabolite A coeluted with B in the 40% methanol fraction.
olites were isolated by offline SPEC-NMR, a procedure that allows the concentration and purification of analytes from complex biological matrices such as urine or plasma (Wilson and Nicholson, 1987) . A urine sample collected at 0 to 8 h postdose was purified using C 8 and C 18 SPEC columns (Bond Elut; Jones Chromatography, Hengoed, Wales, UK). Using the VacElut system, each 2-ml SPEC column was conditioned by washing under vacuum (10 bar) with methanol (2 ml) and then acidified water (2 ml, acidified with formic acid to pH 2). The urine sample (1 ml) was applied to the conditioned column and pulled through slowly under vacuum and the eluate (sample) collected. The column was then washed with water (2 ϫ 1 ml, pH 2) to elute a, 600 MHzall nonretained molecules from the dead volume followed by a step gradient of methanol/water (1 ml) at 20, 40, 60, 80, and 100%. Methanol was removed before all SPEC fractions were lyophilized and reconstituted in D 2 O (400 l) for 1 H NMR spectroscopic analysis. 1 H NMR spectroscopic data of SPEC extracts and whole rat urine were acquired at ambient temperature using a 1D version of the Nuclear Overhauser Enhancement SpectroscopY pulse sequence (Jeener et al., 1979) .
Secondary irradiation of the water signal was achieved during the mixing time t m (150 ms). NMR data of the SPEC extracts were acquired on a Bruker Avance spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) operating at 600.13 MHz. For each spectrum 64 free induction decays (FIDs) were collected into 64 K data points using a spectral width of 12019.23 Hz, an acquisition time of 2.73 s, and a total pulse recycle delay of 4.73 s. NMR data of whole rat urine were acquired on a Bruker DRX 500 operating at 1 H frequency 500.13 MHz. For each spectrum, 400 FIDs were collected into 64 K data points using a spectral width of 8992.81 Hz, an acquisition time of 3.64 s and a total pulse recycle time of 6.64 s. The FIDs acquired at both frequencies were multiplied by an exponential weighting function corresponding to a line broadening of 0.3 Hz prior to Fourier transformation. 2D 1 H-1 H Long-Range Correlation Spectroscopy (Long-Range COSY). A 1 H NMR two-dimensional spectrum of a C 8 SPEC fraction containing both BF metabolites (water wash, pH 2) was acquired on a Bruker Avance spectrometer operating at 600.13 MHz.
1 H NMR spectra were acquired at ambient temperature using a modified version of the long-range correlation spectroscopy (COSY) pulse sequence (Bax and Freeman, 1981 ) using a 1.5 s relaxation delay and a 300 ms delay to allow modulation of the long-range couplings. Two hundred and fifty-six increments with thirty-two FIDs were collected into 2 K data points with a spectral width of 8503.40 Hz.
Analytical Chromatography for HPLC-MS, HPLC-NMR, and HPLC-NMR-MS.
The HPLC method was developed on a Hypersil ODS2 5-m column (250 ϫ 4.6 mm, i.d; Thermo Hypersil-Keystone Ltd., Runcorn, Cheshire, UK) using a step gradient elution with 0.01 M ammonium formate buffer, pH 6.8 (100%), for 10 min; followed by acetonitrile/0.01 M ammonium formate buffer, pH 6.8 (0:100 to 30:70 v/v), from 10 to 35 min; acetonitrile/0.01 M ammonium formate buffer, pH 6.8 (30:70 to 50:50 v/v), from 35 to 45 min; and acetonitrile/0.01 M ammonium formate buffer, pH 6.8 (50:50 v/v), from 45 to 55 min with a flow rate of 1 ml/min. For the HPLC-NMR and HPLC-NMR-MS analyses, ammonium formate buffer was prepared using D 2 O (Philip Harris Scientific, London, UK). For analysis by HPLC-MS, the ammonium formate buffer was prepared using H 2 O. All methods used acetonitrile (Pestanal grade; Riedel de Haen, Seelze, Germany) in the mobile phase.
HPLC-NMR and Mass Spectroscopic Analysis of SPEC Fractions. The HPLC system consisted of a Bruker LC22 pump using a Bischoff 1000 Lambda variable wavelength detector (Bischoff Chromatography, Stuttgart, Germany) operated at 254 nm. Separation was effected at ambient temperature using the HPLC method as described previously. Chromatography was controlled using the Bruker HyStar software operating in the stop-flow mode. For stop-flow 1 H NMR spectra were acquired on a Bruker Avance spectrometer operating at 600.13 MHz using a presaturation pulse sequence, with double presaturation for suppression of the water and acetonitrile signals. Mass spectrometric data were acquired on a Bruker Esquire ion-trap mass spectrometer with electrospray ionization operating in either positive or negative ion modes. Mass spectra were acquired between m/z 100 and 1000. MS-MS experiments were effected by isolation and fragmentation of the peak of interest using helium gas. For HPLC-NMR-MS using mass-directed stopflow NMR detection, a reconstructed ion chromatogram was used to search in negative ion mode for the molecular ion fragment of metabolite B at m/z 218. A 20:1 splitter was positioned immediately after the HPLC column, with 5% of the flow to the mass spectrometer and approximately 95% of the flow to the NMR flow cell via the UV detection cell, using polyether ether ketone tubing. The system was arranged such that the eluent reached the mass spectrometer 6 s before it reached the UV cell. This allowed detection of the peak of interest by MS, before the same peak was observed by UV and subsequently parked in the NMR flow cell for NMR analysis.
Results

H NMR Spectroscopy of Urine and SPEC Fractions of Urine.
The 600 MHz 1 H NMR spectra of SD rat urine samples collected over a 4-day period prior to and after administration of BF are shown in Fig. 1 . Comparison of the pre-and postdose 1 H NMR spectra (Fig. 1 ) and a spectrum of BF (99.5% purity, spectrum not shown) showed that no parent compound was detectable but identified new resonances relating to BF metabolites present in both the 0 to 8 h and 8 to 24 h p.d. urine collections. Signals and consideration of ␦ and J patterns indicated these peaks were from two BF metabolites, termed provisionally metabolite A and metabolite B (Fig. 1) . Visual comparison of the peak intensities and signal-to-noise (s/n) ratio of the BF metabolites present in the 1 H NMR spectra obtained for the 0 to 8 h and 8 to 24 h p.d. urine collections indicated that the 0 to 8 h sample contained 
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at ASPET Journals on July 3, 2017 dmd.aspetjournals.org higher concentrations of BF metabolites. Thus, for metabolite identification, a urine sample collected over the period 0 to 8 h after administration of BF was subjected to SPEC, and the extracts, analyzed by 1 H NMR spectroscopy, confirmed the existence of two BF metabolites. Metabolite A coeluted with metabolite B in the 40% methanol C 18 extract, but the 80% methanol C 18 extract contained only A (Fig. 2) .
Identification of BF Metabolite A. The 80% methanol C 18 extract, containing metabolite A, was re-analyzed using directly coupled HPLC-NMR. The metabolite was isolated in the HPLC-NMR probe, the 1 H NMR spectrum acquired (Fig. 3a) and the eluate containing the peak collected for analysis by ion-trap mass spectrometry (Fig. 3b) . The aromatic splitting pattern of two pairs of doublet (␦7.12 and 6.85) and triplet (␦7.15 and 6.88), together with an integral value corresponding to a total of four aromatic protons, relative to the aliphatic singlet (␦3.46) corresponding to two protons, is characteristic of an ortho substituted phenyl moiety. A 2D long-range COSY experiment (Fig. 4 ) of urine containing BF metabolites A and B established a connectivity between the singlet and the aromatic resonances corresponding to metabolite A. Ion-trap LC-MS of the eluate, operating in positive ion mode, identified the molecular ion with m/z of 153 (Fig.  3b) and a loss of a ϪCO 2 fragment, yielding a base peak at m/z 109. The MS and NMR data were consistent with the structure of 2-hydroxyphenylacetic acid. Authentic 2-hydroxyphenylacetic acid standard spiked into the original SPEC fraction gave exactly coincident resonances, confirming the assignment of metabolite A (data not
FIG. 5. Identification of metabolite B by directly coupled on-flow HPLC-NMR-MS with mass-directed detection.
Analysis by HPLC-NMR-MS and MS was performed on a 40% methanol SPEC fraction. Mass-directed detection of molecular ion at m/z 218 identified the LC peak (Fig. 2b) established four aromatic protons (two doublets at ␦7.43 and ␦7.38 and two triplets at ␦7.34 and ␦7.28) and a pair of methylene protons (triplets at ␦2.98 and ␦3.85).
A 2D
1 H-1 H long-range COSY experiment of a C 8 SPEC fraction (water wash, pH 2) containing BF metabolites A and B (Fig. 4) established connectivities between the pair of triplets at ␦2.98 and ␦3.85, the aromatic resonances between ␦7.28 and ␦7.43, and the triplet at ␦2.98 with the aromatic resonances corresponding to metabolite B. The ortho substitution aromatic splitting pattern and the connectivity between the aliphatic and aromatic resonances indicated that metabolite B could be 2-(2-hydroxyethyl)phenol (2-HEP). However, authentic 2-(2-hydroxyethyl)phenol spiked into a 40% methanol C 18 SPEC extract containing metabolite B showed that the 1 H NMR resonances did not coincide (data not shown).
The 40% methanol C 18 SPEC extract containing metabolite B was analyzed by ion-trap mass spectrometry. Negative-ion mass spectroscopic analysis of the SPEC extract dissolved in H 2 O resulted in a molecular ion with m/z 217, and MS-MS analysis of this molecular ion yielded a fragment with m/z of 137, consistent with the identification of a sulfate conjugate of 2-(2-hydroxyethyl)phenol. When this sample was dissolved in D 2 O, the negative ion mass spectrum (data not shown) resulted in a molecular ion with m/z of 218, and MS-MS analysis of this ion yielded a fragment with m/z of 138, consistent with the loss of one sulfate group (80 mass units). In a D 2 O matrix, all exchangeable protons in the metabolite would exchange with deuterium, thus the molecular ion becomes m/z of 218 (instead of m/z 217). To confirm that the mass spectrum corresponded to metabolite B, the sample was analyzed by directly coupled HPLC-NMR-MS using mass-directed detection in negative ion mode, observing selected ion chromatograms at m/z of 218. The resultant mass spectrum (Fig. 5a ) observed a molecular ion peak with m/z of 218 and the presence of a peak with m/z of 220 at approximately 4% intensity of the m/z 218 molecular ion, consistent with containing the 34 S isotope. The mass spectrum (Fig. 5a ) also showed the presence of fragment ions with two peaks associated with each fragment separated by one mass unit. Since D 2 O was used in the HPLC mobile phase, it would be expected that all exchangeable protons would exchange for deuterium. However, since the eluent was mixed with additional acetonitrile that contains residual H 2 O in addition to the presence of protons from the SPEC process, partial re-exchange of the deuteriums for protons had occurred, complicating the fragmentation pattern observed.
The corresponding HPLC peak was "parked" in the NMR flow cell and the 1 H NMR spectrum acquired (Fig. 5b) . The 1 H NMR and mass spectra indicate the structure to be 2-(2-hydroxyethyl)phenol conju- Key, I ϭ 2,3-benzofuran; II ϭ 2-(2-hydroxyphenyl) ethanal; III ϭ 2-(2-hydroxyphenyl) acetic acid; IV ϭ 2-(2-hydroxyethyl)phenol; V ϭ 2-(2-hydroxyethyl)phenyl hydrogen sulfate. The urinary BF metabolites, 2-hydroxyphenylacetic acid and 2-(2-hydroxyethyl)phenyl hydrogen sulfate, were quantitated using 1 H NMR spectroscopic data. Shown is the total per cent of dose represented for both of these metabolites excreted in the urine Ϯ the standard deviation. gated with one sulfate group but do not identify whether conjugation occurs at the phenolic or the aliphatic hydroxyl position. Sulfate groups are known to cause a down field shift in the 1 H NMR resonances of directly adjacent proton (Kemp, 1991) . The 1 H NMR resonances of metabolite B were compared (Table 1) with those resulting from authentic 2-(2-hydroxyethyl)phenol to establish which signals had shifted down field (to a higher chemical shift value). A down field shift was observed in all of the resonances for metabolite B relative to those of 2-(2-hydroxyethyl)phenol, but the largest shifts were observed in the protons attached directly to the phenyl ring, with a smaller down field shift for the aliphatic protons. Additionally, connectivities from the long-range COSY spectrum (Fig. 4) identified the triplet at ␦2.98 as arising from the aliphatic protons directly adjacent to the aromatic ring (Ar-CH 2 ), and these protons show a greater down field shift than the aliphatic protons furthest from the aromatic ring (Ar-CH 2 -CH 2 -OH). This suggests that sulfate conjugation probably occurred at the phenolic ϪOH. 2-(2-hydroxyethyl)phenyl hydrogen sulfate was observed in all urine samples obtained between 0 and 8 h and between 8 and 24 h postdose.
Quantification of BF Metabolites. The mean percentages of the dose recovered in urine as 2-hydroxyphenylacetic acid (24.3 Ϯ 6.0%) and 2-(2-hydroxyethyl)phenyl hydrogen sulfate (19.6 Ϯ 6.4%) over the first 24 h after dosing BF, as determined by 1 H NMR spectroscopy, are shown in Table 2 . Total recovery of material identified as derived from BF over the 24 h period was 44.0 Ϯ 11.5% of the dose given.
Discussion
The urinary excretion profile and identity of the metabolites of BF following a single i.p. dose at 150 mg/kg in SD rats were determined using a combination of 1 H NMR, HPLC-NMR, and HPLC-NMR-MS. A total of 44.0 Ϯ 11.5% of the dose was eliminated as two urinary metabolites, detectable by 1 H NMR spectroscopy up to 24 h p.d. These metabolites were identified as 2-hydroxyphenylacetic acid (24.3 Ϯ 6.0% of dose) and 2-(2-hydroxyethyl)phenyl hydrogen sulfate (19.6 Ϯ 6.4% of dose).
The proposed mechanism for the metabolism of BF to metabolite A and metabolite B involves formation of the intermediate 2-(2-hydroxyphenyl) ethanal (II, Fig. 6 ). The furan ring is cleaved, probably via cytochrome P450-catalyzed oxidation, to form II. This intermediate is likely to be a substrate either for aldehyde oxidase, yielding metabolite A (III) or for alcohol dehydrogenase yielding the reduced product, 2-(2-hydroxyethyl)phenol sulfate (IV, Fig. 6 ). Sulfation of IV will yield metabolite B (V).
As a methodology for structural characterization of xenobiotic metabolites, directly coupled HPLC-NMR-MS offers the potential for full structural characterization in a single chromatographic run with minimal sample preparation. In this study we have used HPLC-NMR-MS with mass-directed NMR detection and demonstrated how this approach facilitates the structural characterization of metabolites containing "NMR-silent" moieties, as exemplified by the identification of the sulfate group in 2-(2-hydroxyethyl)phenyl hydrogen sulfate.
